v3.25.3
Investments
9 Months Ended
Sep. 30, 2025
Investments [Abstract]  
Investments
Note 11 – Investments
The following table summarizes the Company's investments by category and current or long-term classification:
September 30, 2025December 31, 2024
(In millions)CurrentLong-TermTotalCurrentLong-TermTotal
Debt securities$490 $7,861 $8,351 $463 $8,960 $9,423 
Equity securities17 3,500 3,517 554 561 
Commercial mortgage loans100 1,158 1,258 108 1,243 1,351 
Policy loans 1,080 1,080 — 1,156 1,156 
Other long-term investments 4,884 4,884 — 4,576 4,576 
Short-term investments276  276 170 — 170 
Total$748 $16,489 $17,237 
Investments classified as assets of businesses held for sale (1)
(83)(1,361)(1,444)
Investments per Consolidated Balance Sheets$883 $18,483 $19,366 $665 $15,128 $15,793 
(1) Investments related to the HCSC transaction that were held for sale as of December 31, 2024. These investments were primarily comprised of debt securities.
Investment Portfolio
Debt Securities
The amortized cost and fair value by contractual maturity periods for debt securities were as follows as of September 30, 2025:
(In millions)Amortized
Cost
Fair
Value
Due in one year or less$653 $573 
Due after one year through five years3,649 3,639 
Due after five years through ten years2,103 2,052 
Due after ten years1,978 1,842 
Mortgage and other asset-backed securities271 245 
Total$8,654 $8,351 
Actual maturities of these securities could differ from their contractual maturities used in the table above because issuers may have the right to call or prepay obligations, with or without penalties.
Gross unrealized appreciation (depreciation) on debt securities by type of issuer is shown below:
(In millions)Amortized
Cost
Allowance for Credit LossUnrealized
Appreciation
Unrealized
Depreciation
Fair
Value
September 30, 2025
Federal government and agency$214 $ $16 $(4)$226 
State and local government24  1  25 
Foreign government407  12 (7)412 
Corporate7,738 (118)168 (345)7,443 
Mortgage and other asset-backed271  2 (28)245 
Total$8,654 $(118)$199 $(384)$8,351 
December 31, 2024
Federal government and agency$276 $— $14 $(9)$281 
State and local government37 — (1)37 
Foreign government350 — (11)344 
Corporate9,091 (111)102 (659)8,423 
Mortgage and other asset-backed371 — (34)338 
Total$10,125 $(111)$123 $(714)$9,423 
Review of Declines in Fair Value. Management reviews debt securities in an unrealized loss position to determine whether a credit loss allowance is needed based on criteria that include severity of decline; financial health and specific prospects of the issuer; and changes in the regulatory, economic or general market environment of the issuer's industry or geographic region.
The table below summarizes debt securities with a decline in fair value from amortized cost for which an allowance for credit losses has not been recorded (by investment grade and the length of time these securities have been in an unrealized loss position). Unrealized depreciation on these debt securities is primarily due to declines in fair value resulting from increasing interest rates since these securities were purchased.
September 30, 2025December 31, 2024
(Dollars in millions)Fair
Value
Amortized
Cost
Unrealized
Depreciation
Number
of Issues
Fair
Value
Amortized
Cost
Unrealized
Depreciation
Number
of Issues
One year or less
Investment grade$276 $278 $(2)121$1,203 $1,227 $(24)545 
Below investment grade52 58 (6)252245 250 (5)739 
More than one year
Investment grade3,389 3,747 (358)9184,687 5,319 (632)1,297 
Below investment grade213 231 (18)74416 469 (53)123 
Total$3,930 $4,314 $(384)1,365 $6,551 $7,265 $(714)2,704 
Equity Securities
The following table provides the values of the Company's equity security investments:
September 30, 2025 December 31, 2024
(In millions) CostCarrying Value CostCarrying Value
Equity securities with readily determinable fair values$641 $134 $635 $37 
Equity securities with no readily determinable fair value6,167 3,383 3,215 524 
Total$6,808 $3,517 $3,850 $561 
In the third quarter of 2025, the Company invested $3.5 billion in preferred stock of Shields and a compounding dividend is recorded in Fees and other revenues within the Consolidated Statements of Income. The investment is included in equity securities with no readily determinable fair value in the table above.
Commercial Mortgage Loans
Mortgage loans held by the Company are made exclusively to commercial borrowers and are diversified by property type, location and borrower. Loans are generally issued at fixed rates of interest and are secured by high-quality, primarily completed and substantially leased operating properties.
The Company regularly evaluates and monitors credit risk from the initial mortgage loan underwriting and throughout the investment holding period. The annual portfolio review performed in the second quarter of 2025 confirmed ongoing strong overall credit quality in line with the previous year's results. For more information on the Company's accounting policies and methodologies regarding these investments, see Note 11 in the Company's 2024 Form 10-K.
The following table summarizes the credit risk profile of the Company's commercial mortgage loan portfolio:

(Dollars in millions)September 30, 2025December 31, 2024
Loan-to-Value RatioCarrying ValueAverage Debt Service Coverage RatioAverage Loan-to-Value RatioCarrying ValueAverage Debt Service Coverage RatioAverage Loan-to-Value Ratio
Below 60%$356 2.13$547 2.07
60% to 79%717 1.77595 1.83
80% to 100%185 0.87209 0.51
Total$1,258 1.7271 %$1,351 1.7069 %
Other Long-Term Investments
Other long-term investments include investments in unconsolidated entities, including certain limited partnerships and limited liability companies holding real estate, securities or loans. These investments are carried at cost plus the Company's ownership percentage of reporting income or loss, based on the financial statements of the underlying investments that are generally reported at fair value. Income or loss from these investments is reported on a one-quarter lag due to the timing of when financial information is received from the general partner or manager of the investments.
Other long-term investments also include investment real estate carried at depreciated cost less any impairment write-downs to fair value when cash flow estimates indicate that the carrying value may not be recoverable. Additionally, statutory and other restricted deposits and foreign currency swaps carried at fair value are reported in the table below as Other. The following table provides the carrying value information for these investments:
Carrying Value as of
(In millions)September 30, 2025December 31, 2024
Real estate investments$1,800 $1,763 
Securities partnerships2,896 2,587 
Other188 226 
Total$4,884 $4,576 
Derivative Financial Instruments
The Company uses derivative financial instruments to manage the characteristics of investment assets (such as duration, yield, currency and liquidity) to meet the varying demands of the related insurance and contractholder liabilities. The Company also uses derivative financial instruments to hedge the risk of changes in the net assets of certain of its foreign subsidiaries due to changes in foreign currency exchange rates and to hedge the interest rate risk of certain long-term debt. The Company also has derivative instruments associated with certain equity securities; see Note 12 to the Consolidated Financial Statements for further discussion.
As of September 30, 2025, the notional value of interest rate swap contracts increased to $2.8 billion compared with $2.7 billion as of December 31, 2024. There were no other material changes to the Company's individual derivative hedging strategies during the three and nine months ended September 30, 2025. Please refer to the Company's 2024 Form 10-K for further discussion of the types of derivative financial instruments and associated accounting policies. The effects of derivative financial instruments used in our individual hedging strategies were not material to the Consolidated Financial Statements as of September 30, 2025 and December 31, 2024. The gross fair values of our derivative financial instruments are presented in Note 12 to the Consolidated Financial Statements.
Investment Gains and LossesNet investment gains (losses), before income taxes were $26 million and $76 million, respectively, for the three and nine months ended September 30, 2025, versus $(921) million and $(2,805) million, respectively, for the three and nine months ended September 30, 2024. Net investment results for the three and nine months ended September 30, 2025 increased, reflecting the absence of the impairment of equity securities recorded in 2024. These amounts exclude investment gains and losses attributed to the Company's separate accounts because those gains and losses generally accrue directly to separate account policyholders.